Consequently, these studies indicate that H4R is involved in mediating pruritic responses in humans, and that H4R antagonists are ought to be effective in the treatment of pruritic histamine-mediated conditions, such as AD, acute urticaria, allergic rhinitis, or allergic conjunctivitis. The gene discussed is HRH4; the disease is atopic conjunctivitis.